Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds
Authors:
- B M FarrBFB M Farr
- E M ConnerECE M Conner
- R F BettsRBR F Betts
- J OleskeJOJ Oleske
- A MinneforAMA Minnefor
- J M GwaltneyJGJ M Gwaltney
Open Access
- 1 August 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (8) , 1183-1187
Abstract
The therapeutic efficacy of zinc gluconate lozenge therapy in experimentally induced rhinovirus infection was assessed in two randomized controlled trials in susceptible adult volunteers. In trial 1, lozenges containing either zinc gluconate (23 mg of elemental zinc) or placebo were given 36 h after nasal inoculation of rhinovirus type 39 and administered eight times per day for 5 days. All of the volunteers had early cold symptoms at the time that treatment was begun. In trial 2, the same lozenge regimen was used, beginning 2 h after nasal inoculation with rhinovirus type 13, and continued for 7 days. Zinc therapy did not reduce the severity or duration of cold symptoms or the frequency or duration of viral shedding in either trial. Viral titers were measured in trial 2 and were shown to be unaffected by zinc therapy. Nasal mucus weights and the numbers of paper tissues used were slightly higher in zinc recipients. A statistically significant increase in levels of zinc in serum was documented in zinc recipients after 5 days of therapy. These data suggest that zinc gluconate lozenge therapy is not therapeutically useful in the treatment of rhinovirus colds.Keywords
This publication has 9 references indexed in Scilit:
- In vitro activity of zinc salts against human rhinovirusesAntimicrobial Agents and Chemotherapy, 1987
- Reduction in duration of common colds by zinc gluconate lozenges in a double-blind studyAntimicrobial Agents and Chemotherapy, 1984
- Interruption of Experimental Rhinovirus TransmissionThe Journal of Infectious Diseases, 1980
- Replication of rhinovirusesArchives of Virology, 1976
- Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptidesJournal of Virology, 1976
- Effects of ascorbic acid on the common coldThe American Journal of Medicine, 1975
- Characterization of the Large Picornaviral Polypeptides Produced in the Presence of Zinc IonJournal of Virology, 1974
- Zinc ions inhibit replication of rhinovirusesNature, 1974
- Transmission of the Common Cold to Volunteers Under Controlled ConditionsA.M.A. Archives of Internal Medicine, 1958